PATENT CLAIM ANALYSIS

Application Number: 16206472
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "171000"]

Abstract:
Described herein are neuroactive steroids of the Formula (I): or a pharmaceutically acceptable salt thereof; wherein  , A, R 1 , R 2 , R 3a , R 4a , R 4b , R 5 , R 7a , and R 7b  are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.

Claim (Index 81):
A pharmaceutical composition comprising a pharmaceutically acceptable salt according to  claim 80  and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.51562
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15519480', '15660114', '15552201', '15319504', '15742422']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7767149070081834
- 35 USC 102 Novelty (BERT): 0.5317418132422105
- Combined Prediction Score: 0.752217597631586
- Mean Citation Score: 357.5199320000001
- Max Citation Score: 365.47144
- Similarity Product: 260.2780150333404

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test